Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-09-12
2006-09-12
Fay, Zohreh (Department: 1618)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S669000, C514S912000
Reexamination Certificate
active
07105512
ABSTRACT:
The present invention provides an ophthalmic aqueous pharmaceutical preparation, which is excellent in anti-inflammatory effect, which is less stimulative and which has high safety and excellent storage stability. The ophthalmic aqueous pharmaceutical preparation comprises meloxicam and trometamol.
REFERENCES:
patent: 4829088 (1989-05-01), Doulakas
patent: 1173661 (1969-12-01), None
patent: 0 390 071 (1990-10-01), None
patent: 0 945 134 (1999-09-01), None
patent: 54-92976 (1979-07-01), None
patent: 56-73023 (1981-06-01), None
patent: WO 93/01814 (1993-02-01), None
patent: WO 99/01814 (1993-02-01), None
patent: WO 99/09988 (1993-03-01), None
patent: WO 99/59634 (1999-11-01), None
The Merch Index, Eleventh Edition, 1989.
Derwent Abstract 1993-058509, 200161 (1993).
Morizono Daisuke
Naito Kenji
Suzuki Hidekazu
Takeuchi Masanobu
Fay Zohreh
Wakamoto Pharmaceutical Co., Ltd.
LandOfFree
Ophthalmic aqueous pharmaceutical preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ophthalmic aqueous pharmaceutical preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic aqueous pharmaceutical preparation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3557776